Donald L. Hagan LLC’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-169,514
| Closed | -$150K | – | 123 |
|
|
2022
Q4 | $150K | Buy |
169,514
+20,037
| +13% | +$17.8K | 0.09% | 85 |
|
|
2022
Q3 | $235K | Buy |
149,477
+60,739
| +68% | +$95.5K | 0.17% | 82 |
|
|
2022
Q2 | $178K | Buy |
88,738
+1,804
| +2% | +$3.62K | 0.11% | 91 |
|
|
2022
Q1 | $203K | Buy |
86,934
+13,350
| +18% | +$31.2K | 0.11% | 92 |
|
|
2021
Q4 | $342K | Buy |
73,584
+30,655
| +71% | +$142K | 0.18% | 88 |
|
|
2021
Q3 | $328K | Buy |
42,929
+2,871
| +7% | +$21.9K | 0.19% | 85 |
|
|
2021
Q2 | $388K | Buy |
40,058
+3,935
| +11% | +$38.1K | 0.23% | 79 |
|
|
2021
Q1 | $299K | Buy |
36,123
+11,697
| +48% | +$96.8K | 0.2% | 81 |
|
|
2020
Q4 | $167K | Buy |
24,426
+8,724
| +56% | +$59.6K | 0.12% | 83 |
|
|
2020
Q3 | $175K | Buy |
15,702
+3,600
| +30% | +$40.1K | 0.14% | 78 |
|
|
2020
Q2 | $76K | Sell |
12,102
-13,900
| -53% | -$87.3K | 0.07% | 81 |
|
|
2020
Q1 | $67K | Buy |
26,002
+4,902
| +23% | +$12.6K | 0.06% | 79 |
|
|
2019
Q4 | $89K | Buy |
+21,100
| New | +$89K | 0.08% | 86 |
|